These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15063894)

  • 1. A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy.
    Hillenbrand A; Formentini A; Staib L; Sander S; Salonga D; Danenberg K; Danenberg P; Kornmann M
    Eur J Surg Oncol; 2004 May; 30(4):407-13. PubMed ID: 15063894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.
    Link KH; Kornmann M; Butzer U; Leder G; Sunelaitis E; Pillasch J; Salonga D; Danenberg KD; Danenberg PV; Beger HG
    Cancer; 2000 Jul; 89(2):288-96. PubMed ID: 10918158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine.
    Davies MM; Johnston PG; Kaur S; Allen-Mersh TG
    Clin Cancer Res; 1999 Feb; 5(2):325-8. PubMed ID: 10037181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
    Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
    J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.
    Gonen M; Hummer A; Zervoudakis A; Sullivan D; Fong Y; Banerjee D; Klimstra D; Cordon-Cardo C; Bertino J; Kemeny N
    J Clin Oncol; 2003 Feb; 21(3):406-12. PubMed ID: 12560427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy.
    Libra M; Navolanic PM; Talamini R; Cecchin E; Sartor F; Tumolo S; Masier S; Travali S; Boiocchi M; Toffoli G
    BMC Cancer; 2004 Mar; 4():11. PubMed ID: 15040806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
    Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival.
    Bathe OF; Franceschi D; Livingstone AS; Moffat FL; Tian E; Ardalan B
    Cancer J Sci Am; 1999; 5(1):34-40. PubMed ID: 10188059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy.
    Kornmann M; Link KH; Lenz HJ; Pillasch J; Metzger R; Butzer U; Leder GH; Weindel M; Safi F; Danenberg KD; Beger HG; Danenberg PV
    Cancer Lett; 1997 Sep; 118(1):29-35. PubMed ID: 9310257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
    Maithel SK; Gönen M; Ito H; Dematteo RP; Allen PJ; Fong Y; Blumgart LH; Jarnagin WR; D'Angelica MI
    Surgery; 2012 Feb; 151(2):162-70. PubMed ID: 21982065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
    Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
    Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
    Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer.
    Corsi DC; Ciaparrone M; Zannoni G; Mancini M; Cassano A; Specchia M; Pozzo C; Martini M; Barone C
    Eur J Cancer; 2002 Mar; 38(4):527-34. PubMed ID: 11872345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
    Berglund A; Edler D; Molin D; Nordlinder H; Graf W; Glimelius B
    Anticancer Res; 2002; 22(6B):3653-9. PubMed ID: 12552972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.
    Barber FD; Mavligit G; Kurzrock R
    Cancer Treat Rev; 2004 Aug; 30(5):425-36. PubMed ID: 15245775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.